| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 01/03/2023 | Coya Therapeutics, Inc. | | Purchase | Warrant to Purchase Common Stock | 5k | $7.50 | $37.5k | | 01/03/2023 |
| 01/03/2023 | Coya Therapeutics, Inc. | | Purchase | Common Stock, par value $0.0001 per share | 10k | $0.00 | $0 | | 01/03/2023 |
| 09/20/2022 | Gain Therapeutics, Inc. | | Grant | Stock Option (right to buy) | 10.5k | $3.50 | $36.8k | | 09/20/2022 |
| 09/09/2022 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 37.6k | $0.60 | $22.6k | | 09/09/2022 |
| 08/19/2021 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 38.1k | $3.36 | $128.1k | | 08/19/2021 |
| 06/18/2021 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common Stock | 8k | $4.75 | $38k | | 06/18/2021 |
| 09/09/2020 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 14.6k | $8.80 | $128.8k | | 09/09/2020 |
| 04/30/2020 | NeuBase Therapeutics, Inc. | OHRP | Purchase | Common Stock | 10k | $6.00 | $60k | | 04/30/2020 |
| 02/28/2020 | ADMA BIOLOGICS, INC. | ADMA | Grant | Common Stock | 7.5k | $0.00 | $0 | | 02/28/2020 |
| 02/28/2020 | ADMA BIOLOGICS, INC. | ADMA | Grant | Employee Stock Option (right to buy) | 15k | $2.92 | $43.7k | | 02/28/2020 |
| 02/28/2020 | ADMA BIOLOGICS, INC. | ADMA | Grant | Common Stock | 7.5k | $0.00 | $0 | | 02/28/2020 |
| 07/12/2019 | NeuBase Therapeutics, Inc. | OHRP | Grant | Stock option (right to buy) | 227.3k | $5.39 | $1.2M | | 07/12/2019 |
| 03/13/2019 | ADMA BIOLOGICS, INC. | ADMA | Grant | Stock Option (right to buy) | 30k | $3.89 | $116.7k | | 03/13/2019 |
| 06/22/2018 | ADMA BIOLOGICS, INC. | ADMA | Grant | Stock Option (right to buy) | 17.5k | $4.91 | $85.9k | | 06/22/2018 |
| 06/06/2018 | Esperion Therapeutics, Inc. | ESPR | Other (disposition) | Common Stock | 8k | $0.00 | $0 | | 06/06/2018 |
| 06/06/2018 | Esperion Therapeutics, Inc. | ESPR | Exercise | Stock Option (right to buy) | 8k | $17.75 | $142k | | 06/06/2018 |
| 06/06/2018 | Esperion Therapeutics, Inc. | ESPR | Exercise | Stock Option (right to buy) | 5k | $14.42 | $72.1k | | 06/06/2018 |
| 06/06/2018 | Esperion Therapeutics, Inc. | ESPR | Other (disposition) | Common Stock | 5k | $0.00 | $0 | | 06/06/2018 |
| 05/23/2018 | Esperion Therapeutics, Inc. | ESPR | Grant | Stock Option (right to buy) | 10.1k | $38.32 | $387k | | 05/23/2018 |
| 12/18/2017 | Esperion Therapeutics, Inc. | ESPR | Other (disposition) | Common Stock | 21.5k | $0.00 | $0 | | 12/18/2017 |
| 12/18/2017 | Esperion Therapeutics, Inc. | ESPR | Exercise | Stock Option (right to buy) | 21.5k | $3.70 | $79.4k | | 12/18/2017 |
| 12/05/2017 | Esperion Therapeutics, Inc. | ESPR | Other (acquisition) | Common Stock | 38 | $0.00 | $0 | | 12/05/2017 |
| 06/06/2017 | ADMA BIOLOGICS, INC. | ADMA | Grant | Stock Option (right to buy) | 53.8k | $3.66 | $197k | | 06/06/2017 |
| 07/24/2012 | Durata Therapeutics, Inc. | DRTX | Conversion | Series A Preferred Stock | 16.2M | $0.00 | $0 | By Aisling Capital III, LP | 07/24/2012 |
| 07/24/2012 | Durata Therapeutics, Inc. | DRTX | Purchase | Common Stock | 1.1M | $9.00 | $10M | By Aisling Capital III, LP | 07/24/2012 |
| 07/24/2012 | Durata Therapeutics, Inc. | DRTX | Conversion | Common Stock | 2M | $0.00 | $0 | By Aisling Capital III, LP | 07/24/2012 |